HENWOOD GERALDINE (President and CEO) purchased 2.3% of their position (8.20K shares) of BAUDAX BIO, INC. on the open market
Open‑market purchase worth $4.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/23/2021ACC: 0001192482-21-000728
DirectorOfficer· President and CEO
Since Nov 2019
+8.20K
Net shares
Net buyer
$4.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
8.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8.20K
Price / share
$0.59
Trade value
$4.80K
% of position
2.3%
9/22/2021
356.31K→364.51K
Total
Net shares
+8.20K
Net value
$4.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/22/2021 | P · Purchase | +8.20K | $0.59 | $4.80K | 2.3% | 356.31K | 364.51K |
| Total | +8.20K | $4.80K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned20K
Total
20K indirect20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20K | Indirect |
| Total | 20K | 20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported